什么是肠漏?人类临床方面的考虑。
What is the leaky gut? Clinical considerations in humans.
机构信息
Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
出版信息
Curr Opin Clin Nutr Metab Care. 2021 Sep 1;24(5):473-482. doi: 10.1097/MCO.0000000000000778.
PURPOSE OF REVIEW
To review the components of the intestinal barrier, the practical measurements of intestinal permeability, and the clinical conditions associated with altered intestinal barrier function, and to summarize the effects of dietary substances that fortify or weaken the intestinal barrier.
RECENT FINDINGS
The intestinal barrier includes surface mucus, epithelial layer, and immune defense mechanisms. Transport across the epithelium may result from increased paracellular transport, apoptosis, or transcellular permeability. Assessment of the intestinal barrier requires measurements beyond the transport across the epithelial layer or the measurement of tight junction expression. Barrier function is most meaningfully tested in vivo using orally administered probe molecules; other approaches are performed in vitro using mucosal biopsies from humans, or exposing colonic mucosa from rats or mice or cell layers to extracts of colonic mucosa or stool from patients. Dietary factors can influence intestinal leakiness: fortifying the barrier with vitamins A and D, zinc, short-chain fatty acids, methionine, glutamine, and probiotics; weakening of the barrier has been reported with fat, bile acids, emulsifiers, and gliadin. Intestinal mucosal leakiness in 'stress' disorders such as major burns is reversed with enteral glutamine.
SUMMARY
Inflammatory or ulcerating intestinal diseases result in leakiness of the gut barrier; however, no such disease has been cured by simply normalizing intestinal barrier function. Similarly, it is still unproven that restoring barrier function (reversing 'leaky gut') can ameliorate clinical manifestations in nonulcerating gastrointestinal disease or systemic or neurological diseases. On the other hand, dietary and enteral interventions can fortify the intestinal barrier in stress-associated states.
目的综述
肠道屏障的组成部分,肠道通透性的实际测量,以及与肠道屏障功能改变相关的临床情况,并总结强化或削弱肠道屏障的膳食物质的作用。
最近的发现
肠道屏障包括表面黏液、上皮层和免疫防御机制。穿过上皮层的转运可能是由于细胞旁转运增加、细胞凋亡或细胞通透性增加所致。肠道屏障的评估需要超出上皮层转运的测量或紧密连接表达的测量。在体内最有意义的是使用口服给予的探针分子来测试屏障功能;其他方法是在体外使用来自人类的黏膜活检,或暴露大鼠或小鼠的结肠黏膜或细胞层来提取结肠黏膜或粪便中的物质来自患者。膳食因素可以影响肠道通透性:用维生素 A 和 D、锌、短链脂肪酸、蛋氨酸、谷氨酰胺和益生菌来强化屏障;据报道,脂肪、胆汁酸、乳化剂和麦胶蛋白会削弱屏障。在严重烧伤等“应激”障碍中,肠内谷氨酰胺可逆转肠道黏膜通透性。
总结
炎症或溃疡性肠道疾病导致肠道屏障通透性增加;然而,仅仅通过正常化肠道屏障功能并不能治愈此类疾病。同样,尚未证明恢复屏障功能(逆转“肠道渗漏”)可以改善非溃疡性胃肠道疾病或全身性或神经退行性疾病的临床表现。另一方面,饮食和肠内干预可以在应激相关状态下强化肠道屏障。